|
LOC284441 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.718400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.218500E-04 |
| Normal-vs-Stage2 |
3.396000E-01 |
| Normal-vs-Stage3 |
6.543600E-01 |
| Normal-vs-Stage4 |
4.047000E-01 |
| Stage1-vs-Stage2 |
1.675420E-01 |
| Stage1-vs-Stage3 |
2.672300E-02 |
| Stage1-vs-Stage4 |
4.875400E-01 |
| Stage2-vs-Stage3 |
6.567400E-01 |
| Stage2-vs-Stage4 |
8.077000E-01 |
| Stage3-vs-Stage4 |
5.617000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.603800E-04 |
| Normal-vs-AfricanAmerican |
2.937900E-02 |
| Normal-vs-Asian |
3.923600E-01 |
| Caucasian-vs-AfricanAmerican |
4.500400E-01 |
| Caucasian-vs-Asian |
9.515400E-01 |
| AfricanAmerican-vs-Asian |
8.466800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.639290E-04 |
| Normal-vs-Female |
8.565600E-01 |
| Male-vs-Female |
7.841800000008E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.609750E-02 |
| Normal-vs-Extreme_Weight |
1.30149999999496E-06 |
| Normal-vs-Obese |
1.873820E-01 |
| Normal-vs-Extreme_Obese |
1.235540E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.310210E-01 |
| Normal_Weight-vs-Obese |
2.379600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.128000E-01 |
| Extreme_Weight-vs-Obese |
1.324520E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.059000E-01 |
| Obese-vs-Extreme_Obese |
2.237000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.483600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.108300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.220390E-04 |
| Normal-vs-Age(81-100Yrs) |
2.825000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.778800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.013440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.884300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.728400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.102210E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.735840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.69659999999761E-05 |
| Normal-VS-Type2 PRCC |
7.850400E-02 |
| Normal-VS-KIRP CIMP |
8.702400E-02 |
| Normal-VS-Unclassified PRCC |
4.969600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.804500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.655300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.114000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.317550E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.097800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.976130E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.616400E-04 |
| Normal-vs-N1 |
5.730400E-01 |
| Normal-vs-N2 |
3.624600E-01 |
| N0-vs-N1 |
1.489550E-02 |
| N0-vs-N2 |
5.998000E-01 |
| N1-vs-N2 |
4.705200E-01 |
|
|
